title: Reply to Giandomenico Roviello, Alberto Bottini, and Daniele Generali's Letter to the Editor re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035. Corticosteroid-associated Adverse Events in Elderly Patients.
authors.affiliation: Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: karim.fizazi@igr.fr.
authors.forename: Karim
authors.initials: K
authors.lastname: Fizazi
authors.affiliation: Janssen Research & Development, Beerse, Belgium.
authors.forename: Peter
authors.initials: P
authors.lastname: De Porre
authors.affiliation: Janssen Research & Development, Horsham, PA, USA.
authors.forename: Anil
authors.initials: A
authors.lastname: Londhe
authors.affiliation: Janssen Scientific Affairs, Horsham, PA, USA.
authors.forename: Tracy
authors.initials: T
authors.lastname: McGowan
authors.affiliation: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Ryan
mesh_terms: D000069501:Abiraterone Acetate; D000305:Adrenal Cortex Hormones; D000368:Aged; D006801:Humans; D015994:Incidence; D008297:Male; D011241:Prednisone; D064129:Prostatic Neoplasms, Castration-Resistant
chemical_list: D000305:Adrenal Cortex Hormones; D000069501:Abiraterone Acetate; D011241:Prednisone